Cryptic metabolites and method for activating silent biosynthetic gene clusters in diverse microorganisms
Disclosed herein is a rapid genetics-free method for eliciting and detecting cryptic metabolites using an imaging mass spectrometry-based approach. An organism of choice is challenged with elicitors from a small molecule library. The molecules elicited are then imaged by mass spec, which allows for rapid identification of cryptic metabolites. These are then isolated and characterized. Employing the disclosed approach activated production of cryptic glycopeptides from an actinomycete bacterium. The molecules that result, the keratinimicins and keratinicyclins, are metabolites with important structural features. At least two of these, keratinimicins B and C, are highly bioactive against several pathogenic strains. This approach will allow for rapid activation and identification of cryptic metabolites from diverse microorganisms in the future.
1. A method of inhibiting growth of bacteria or viruses, comprising contacting a microorganism with at least one compound having a molecular structure selected from:
a pharmaceutically acceptable salt of (V)-(VII), or a combination thereof.
2. The method according to claim 1 , wherein the microorganism is a gram-positive bacterium.
3. The method according to claim 2 , wherein the gram-positive bacterium is a species selected from the group consisting of: Staphylococcus aureus, Streptococcus agalactiae, Streptococcus pyogenes, Streptococcus pneumoniae, Clostridium difficile, Enterococcus faecalis, and Bacillus subtilis.
4. The method according to claim 1 , wherein the microorganism is a virus.
5. The method according to claim 4 , wherein the virus is respiratory syncytial virus (RSV).